课题基金 / 基金详情

Modulation of innate and adaptive immunity by novel HCV-encoded TLR7 and 8 ligands

Modulation of innate and adaptive immunity by novel HCV-encoded TLR7 and 8 ligands
新型 HCV 编码的 TLR7 和 8 配体调节先天性和适应性免疫
批准号：
198512
负责人：
Shoukry Naglaa H
金额：
$7.28万
依托单位：
Centre hospitalier de l'Universit de Montral (CHUM)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2009
资助国家：
加拿大
项目状态：
已结题
起止时间：
2009-09-01 至 2010-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=198512&lang=en
关键词：
Dendritic Cells Hepatitis C Innate Immunity Interferon T Lymphocytes Tlr

项目摘要

项目成果

Shoukry Naglaa H的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In the vast majority of cases, hepatitis C virus (HCV) is able to establish chronic infection that often progresses to end-stage liver disease and even liver cancer. There is no vaccine to prevent hepatitis C and the present treatment is effective in onl
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sex-Dependent Role of IL22 during Metabolic Dysfunction-associated Liver Disease (MASLD)
Canadian Network on Hepatitis C (CanHepC): From Discovery to Implementation
Signatures of protective immunity against HCV
The National CIHR Hepatitis C Network (NCHCN)
海外基金